Table 4.
Comparisons of TD patients with a single affected area and those with multiple affected areas
| Variables | Single affected area group (n=21) | Multiple affected areas group (n=25) | Statistics | p value | |
|---|---|---|---|---|---|
| Males (%) | 16(76.2%) | 20(80%) | X2=8.37 | 0.004b | |
| Mean (sd) age | 57.10(8.596) | 58.44(8.617) | F=0.27 | 0.600 | |
| Mean (sd) duration of illness | 24.33(11.451) | 31.56(9.147) | F=0.834 | 0.366 | |
| Mean (sd) age of onset | 26.88(6.240) | 22.38(4.717) | F=7.368 | 0.009b | |
| Patient medication use (%) | Single-drug | 7(33.3%) | 8(32%) | X2=0.01 | 0.916 |
| Multiple-drug | 14(66.7) | 17(68%) | |||
| Mean (sd) mg/d Chlorpromazine equivalent | 555.14(256.732) | 588.12(206.158) | F=0.23 | 0.631 | |
| AIMS | Total score (points) | 4.33(1.197) | 8.20(3.841) | F=19.62 | <0.001 c |
| Severity | 15.82 | 29.96 | Z=-3.80 | <0.001 c | |
| Loss of movement ability | 17.83 | 28.26 | Z=-2.75 | 0.005 b | |
| Self-awareness | 23.21 | 23.74 | Z=-0.15 | 0.897 | |
| Mean (sd) PANSS score | Total score | 94.90(16.950) | 94.96(16.336) | F=0.000 | 0.991 |
| Positive symptom factor score | 20.80(5.728) | 21.50(6.865) | F=0.002 | 0.966 | |
| Negative symptom factor score | 37.94(11.956) | 38.52(13.493) | F=0.55 | 0.462 | |
| General psychopathological scale factor score | 40.24(11.912) | 41.92(11.807) | F=0.23 | 0.634 | |
Notes: The ranked data were recorded with the average rank sum; bp<0.01, cp<0.001.